“Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative.”, Pediatr Nephrol, vol. 29, no. 9, pp. 1477-84, 2014.
, “Descriptions of benefits and risks in consent forms for phase 1 oncology trials.”, N Engl J Med, vol. 347, no. 26, pp. 2134-40, 2002.
, “Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients.”, J Pediatr, vol. 156, no. 2, pp. 270-6.e1, 2010.
, “Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry.”, Pediatr Nephrol, vol. 32, no. 12, pp. 2319-2330, 2017.
, “BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry.”, Clin J Am Soc Nephrol, vol. 2, no. 5, pp. 1037-42, 2007.
, “Association between clinical risk factors and progression of chronic kidney disease in children.”, Clin J Am Soc Nephrol, vol. 5, no. 12, pp. 2172-9, 2010.
, “Anemia and risk of hospitalization in pediatric chronic kidney disease.”, Clin J Am Soc Nephrol, vol. 4, no. 1, pp. 48-56, 2009.
, “Anemia and growth status in pediatric patients receiving maintenance dialysis after a failed renal transplant course: an NAPRTCS report.”, Pediatr Transplant, vol. 11, no. 2, pp. 201-4, 2007.
,